MD Anderson Early Detection Research Results Released
MD Anderson released results from an 11-year ovarian cancer screening study following 4,000 women. The women received yearly blood tests checking their CA-125 levels, which is produced by most ovarian tumors. Women who had sudden increases in their CA-125 were sent for an ultrasound and to see a gynecologist. The study suggested that the testing strategy had a specificity of 99.9 percent, the researchers said, meaning that only 0.1 percent of patients without cancer would be falsely identified as having the disease Read a full overview here, including information about a similar study in the UK expected to come out in 2015.